Abstract
P187 Secukinumab significantly decreased joint synovitis measured by Power Doppler ultrasonography in biologic-naive patients with active psoriatic arthritis: primary (12week) results from a randomised, placebo-controlled Phase 3 study
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have